Big Pharma Split Corp.
TSX:PRM.TO
13.15 (CAD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) CAD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 0.312 | 3.711 | 5.359 | 0.589 | 2.434 | 3.232 | 0.407 |
| Cost of Revenue
| 0.309 | 0.42 | 0.356 | 0.277 | 0.238 | 0.275 | 0 |
| Gross Profit
| 0.003 | 3.291 | 5.003 | 0.312 | 2.196 | 2.957 | 0.407 |
| Gross Profit Ratio
| 0.01 | 0.887 | 0.934 | 0.529 | 0.902 | 0.915 | 1 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0.335 | 0.358 | 0.371 | 0.216 | 0.287 | 0.32 | 0.078 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 0.335 | 0.358 | 0.371 | 0.216 | 0.287 | 0.32 | 0.078 |
| Other Expenses
| -3.027 | 0.207 | 0.135 | 0.108 | 0.109 | 0.132 | 0.006 |
| Operating Expenses
| 0.451 | 0.565 | 0.506 | 0.324 | 0.396 | 0.452 | 0.084 |
| Operating Income
| -0.14 | 3.146 | 4.854 | 0.265 | 0.455 | 5.949 | 0.323 |
| Operating Income Ratio
| -0.448 | 0.848 | 0.906 | 0.45 | 0.187 | 1.841 | 0.794 |
| Total Other Income Expenses Net
| -0.506 | -2.617 | 0 | -0.483 | 1.345 | -3.169 | -4.142 |
| Income Before Tax
| -0.14 | 3.146 | 4.854 | 0.265 | 3.144 | 2.78 | 0.323 |
| Income Before Tax Ratio
| -0.448 | 0.848 | 0.906 | 0.45 | 1.292 | 0.86 | 0.794 |
| Income Tax Expense
| -0.645 | 2.389 | 4.21 | -0.217 | -1.345 | 3.169 | -3.818 |
| Net Income
| -0.14 | 3.146 | 4.854 | 0.265 | 4.489 | 2.78 | 0.323 |
| Net Income Ratio
| -0.448 | 0.848 | 0.906 | 0.45 | 1.844 | 0.86 | 0.794 |
| EPS
| -0.11 | 1.58 | 3.27 | -0.22 | 3.75 | 2.06 | -0.23 |
| EPS Diluted
| -0.11 | 1.58 | 3.27 | -0.22 | 3.75 | 2.06 | -0.23 |
| EBITDA
| -0.14 | -3.373 | 0 | 0 | 0.455 | 2.105 | 0.323 |
| EBITDA Ratio
| -0.448 | 0.848 | 0.906 | 0.45 | 0.187 | 2.821 | 0.794 |